Sophie Guia

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing.

Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing.

Journal: Journal for immunotherapy of cancer

Published: March 17, 2025

Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer.

Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer.

Journal: Frontiers in immunology

Published: March 17, 2022

Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response.

Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response.

Journal: Frontiers in immunology

Published: September 01, 2021

Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor.

Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor.

Journal: Cancers

Published: April 23, 2021

Helper-like Innate Lymphoid Cells in Humans and Mice.

Helper-like Innate Lymphoid Cells in Humans and Mice.

Journal: Trends in immunology

Published: October 23, 2019

β2-adrenergic signals downregulate the innate immune response and reduce host resistance to viral infection.

β2-adrenergic signals downregulate the innate immune response and reduce host resistance to viral infection.

Journal: The Journal of experimental medicine

Published: March 27, 2019

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

Journal: Cell

Published: June 13, 2018

Activating and inhibitory receptors expressed on innate lymphoid cells.

Activating and inhibitory receptors expressed on innate lymphoid cells.

Journal: Seminars in immunopathology

Published: January 30, 2018

Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells.

Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells.

Journal: The Journal of experimental medicine

Published: June 09, 2017

Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.

Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.

Journal: Science immunology

Published: May 09, 2017

Manufacturing Natural Killer Cells as Medicinal Products.

Manufacturing Natural Killer Cells as Medicinal Products.

Journal: Frontiers in immunology

Published: July 28, 2016

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival.

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival.

Journal: The Journal of experimental medicine

Published: June 08, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026